from BUSINESS LINE, August 05, 2008 The European Union's nod to Orchid Chemicals & Pharmaceuticals for selling generic Piperacillin Tazobactam (Tazo-Pip) injections is major positive.
Tazo-Pip, an antibacterial combination product used for the treatment of moderate to severe infections, has a $250 million market (over Rs 1,000 crore) in the EU.
It was one of the fastest growing antibiotic injectables in 2007, growing by 19 per cent.
Money spinner The Orchid stock closed nearly 4 per cent up at Rs 259.40 on the NSE. Sandoz and Orchid are the only generic companies with approved facilities for injectable penicillin and this makes the product (launch …